Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
97.912,12
-0,78%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Iovance Biotherapeutics Inc (IOVA) Iovance Biotherapeutics Inc (IOVA) Notizie

Iovance Biotherapeutics Inc

IOVA
7,49
0,03 (0,40%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202423:00GLOBEIovance Biotherapeutics Reports Inducement Grants under..
18/12/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202423:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/12/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202423:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/11/202422:01GLOBEIovance Biotherapeutics Announces the Promotion of Raj Puri,..
21/11/202423:15EDGAR2Form 8-K - Current report
07/11/202423:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:06EDGAR2Form 8-K - Current report
07/11/202422:01GLOBEIovance Biotherapeutics Reports Financial Results and..
31/10/202421:01GLOBEIovance Biotherapeutics to Host Third Quarter and..
17/10/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202423:00GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
16/8/202423:00GLOBEIovance Biotherapeutics Reports Inducement Grants under..
09/8/202423:16EDGAR2Form 8-K - Current report
08/8/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:01GLOBEIovance Biotherapeutics Reports Financial Results and..
29/7/202422:01GLOBEIovance Biotherapeutics to Host Second Quarter and First..
19/7/202423:00GLOBEIovance Biotherapeutics Reports Inducement Grants under..
18/7/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202413:00GLOBEIovance Biotherapeutics Submits Marketing Authorization..
21/6/202423:00GLOBEIovance Biotherapeutics Reports Inducement Grants under..
14/6/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202423:15EDGAR2Form 8-K - Current report
06/6/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202414:01EDGAR2Form 8-K - Current report
24/5/202422:01GLOBEIovance Biotherapeutics to Present at Upcoming Conferences..
23/5/202423:00GLOBEIovance Biotherapeutics Announces Clinical Data in Frontline..
17/5/202423:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/5/202423:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
09/5/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:06EDGAR2Form 8-K - Current report
09/5/202422:01GLOBEIovance Biotherapeutics Reports First Quarter 2024 Financial..
01/5/202412:01GLOBEIovance Biotherapeutics to Host First Quarter 2024 Financial..
30/4/202412:01GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
24/4/202422:01GLOBEIovance Biotherapeutics to Present Clinical and..
19/4/202423:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
Apertura: 7,45 Min: 7,24 Max: 7,50
Chiusura: 7,46

La tua Cronologia

NASDAQ
IOVA
Iovance Biotherapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network